Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 13, 2008
Partin Tables cannot accurately predict the pathological stage at radical prostatectomyN Bhojani, S Ahyai, M Graefen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 2009
[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based studyT Steuber, T Schlomm, H Heinzer, et al.
European Urology Focus|March 14, 2018
Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control StudyT Steuber, C Jilg, P Tennstedt, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|December 16, 2014
Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose TreosulfanM Vogelhuber, S Feyerabend, A Stenzl, et al.
British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.
Folia Biologica|December 19, 2003
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome studyE Huland, A Burger, J Fleischer, et al.
Pageof 5